Crossmark

Extracellular vesicle–based drug delivery in cancer immunotherapy

Crossref DOI link: https://doi.org/10.1007/s13346-023-01370-3

Published Online: 2023-06-01

Published Print: 2023-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Najafi, Sajad

Majidpoor, Jamal

Mortezaee, Keywan https://orcid.org/0000-0003-2004-3465
License Information

Text and Data Mining valid from 2023-06-01

Version of Record valid from 2023-06-01
More Information

Article History

Accepted: 18 May 2023

First Online: 1 June 2023

Declarations

:

: Not applicable.

: The authors declare no competing interests.